awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36402095-12B82186-83AB-45E3-BB6C-C10C7759DABD
Q36402095-12B82186-83AB-45E3-BB6C-C10C7759DABD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36402095-12B82186-83AB-45E3-BB6C-C10C7759DABD
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial.
P2860
Q36402095-12B82186-83AB-45E3-BB6C-C10C7759DABD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36402095-12B82186-83AB-45E3-BB6C-C10C7759DABD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
385b357e66ef22926cba5e8c21923ed8fb51e91e
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.